Core Viewpoint - Brother Technology Co., Ltd. plans to raise up to 436.75 million yuan through a private placement of A-shares to fund the construction of a 600-ton iodinated contrast agent raw material project, expanding its production capacity from 100 tons to 700 tons [1][4]. Group 1: Fundraising and Project Details - The total amount to be raised is capped at 436.75 million yuan, which will be used specifically for the construction of the 600-ton iodinated contrast agent raw material project [1][4]. - The project aims to increase the production capacity of iodinated contrast agent raw materials significantly, enhancing the company's market position [1][4]. Group 2: Risks and Challenges - The project faces multiple risks, including the potential inability to absorb the new production capacity if market demand does not meet expectations or if sales channels are not effectively expanded [2][3]. - The company has experienced significant revenue and profit fluctuations, with a reported loss in 2023 due to declining product prices, which raises concerns about future performance [2][3]. - The fine chemical industry is subject to cyclical fluctuations, and the company’s products are influenced by various factors that can lead to price volatility and impact profit margins [3][4]. Group 3: Issuance and Regulatory Information - The issuance will involve no more than 35 specific investors, with the share price set at no less than 80% of the average trading price over the previous 20 trading days [4]. - The total number of shares issued will not exceed 30% of the company's total share capital prior to the issuance, amounting to a maximum of 31.91 million shares [4].